CLNN

SEC source: 0001596771-22-000001 · primary_doc.xml · derivative · entry 3

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires 2021-12-30

F1 · ownership.nature: The securities are owned by Kensington Investments, L.P. ("KI"). Ms. Mosca is the president of Kensington Management LLC, which is the general partner of KI, and also serves as the trustee of the Robert C. Gay Revocable Trust, which is the limited partner of KI. The securities owned by KI may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all securities owned by KI, for which she does not have a pecuniary or profits interest.

SEC source: 0001596771-22-000001 · primary_doc.xml · nonDerivative · entry 2

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 1,459,945

F2 · ownership.nature: The securities are owned by the Robert C. Gay 1998 Family Trust. Ms. Mosca is the trustee of the Robert C. Gay 1998 Family Trust. The securities owned by the Robert C. Gay 1998 Family Trust may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca has no pecuniary or profits interest in the securities held by the Robert C. Gay 1998 Family Trust.

SEC source: 0001596771-22-000001 · primary_doc.xml · nonDerivative · entry 1

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By LP

Disclosed balance after: 3,006,670

F1 · ownership.nature: The securities are owned by Kensington Investments, L.P. ("KI"). Ms. Mosca is the president of Kensington Management LLC, which is the general partner of KI, and also serves as the trustee of the Robert C. Gay Revocable Trust, which is the limited partner of KI. The securities owned by KI may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all securities owned by KI, for which she does not have a pecuniary or profits interest.

SEC source: 0001562180-21-005202 · primarydocument.xml · derivative · entry 1

Gay Jonathon · CIK 0001835422 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,635

Underlying: Common Stock · 1,635 shares

Expires 2031-08-05

F1 · derivative.exercise_date: This option was granted on August 5, 2021 as an option for 1,635 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.37 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-005201 · primarydocument.xml · derivative · entry 1

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,899

Underlying: Common Stock · 2,899 shares

Expires 2031-08-05

F1 · derivative.exercise_date: This option was granted on August 5, 2021 as an option for 2,899 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.37 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-005203 · primarydocument.xml · derivative · entry 1

Stevens John Henry · CIK 0001835543 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,710

Underlying: Common Stock · 1,710 shares

Expires 2031-08-05

F1 · derivative.exercise_date: This option was granted on August 5, 2021 as an option for 1,710 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.37 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-005200 · primarydocument.xml · derivative · entry 1

Jacobovitz Shalom · CIK 0001835556 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,212

Underlying: Common Stock · 2,212 shares

Expires 2031-08-05

F1 · derivative.exercise_date: This option was granted on August 5, 2021 as an option for 2,212 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.37 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-005199 · primarydocument.xml · derivative · entry 1

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,267

Underlying: Common Stock · 2,267 shares

Expires 2031-08-05

F1 · derivative.exercise_date: This option was granted on August 5, 2021 as an option for 2,267 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.37 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-005198 · primarydocument.xml · derivative · entry 1

Ugwumba Chidozie · CIK 0001835544 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,766

Underlying: Common Stock · 1,766 shares

Expires 2031-08-05

F1 · derivative.exercise_date: This option was granted on August 5, 2021 as an option for 1,766 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.37 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-004942 · primarydocument.xml · nonDerivative · entry 1

WILCOX REED N · CIK 0001266609 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 27,784

F1 · shares: This stock award was granted on July 14, 2021 under the Clene Inc. 2020 Stock Plan. The award fully vests on the date of grant.

SEC source: 0001562180-21-004958 · primarydocument.xml · nonDerivative · entry 1

Gay Jonathon · CIK 0001835422 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,783

F1 · shares: This stock award was granted on July 14, 2021 under the Clene Inc. 2020 Stock Plan. The award fully vests on the date of grant.

SEC source: 0001562180-21-004955 · primarydocument.xml · nonDerivative · entry 1

Stevens John Henry · CIK 0001835543 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,378

F1 · shares: This stock award was granted on July 14, 2021 under the Clene Inc. 2020 Stock Plan. The award fully vests on the date of grant.

SEC source: 0001562180-21-004957 · primarydocument.xml · nonDerivative · entry 1

Jacobovitz Shalom · CIK 0001835556 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,838

F1 · shares: This stock award was granted on July 14, 2021 under the Clene Inc. 2020 Stock Plan. The award fully vests on the date of grant.

SEC source: 0001562180-21-004956 · primarydocument.xml · nonDerivative · entry 1

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,083

F1 · shares: This stock award was granted on July 14, 2021 under the Clene Inc. 2020 Stock Plan. The award fully vests on the date of grant.

SEC source: 0001562180-21-004606 · primarydocument.xml · nonDerivative · entry 1

Mortenson Mark · CIK 0001835427 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 50,082

F1 · shares: This restricted stock award was granted on June 30, 2021 under the Clene Inc. 2020 Stock Plan. The award fully vests on January 15, 2022.

SEC source: 0001562180-21-004607 · primarydocument.xml · nonDerivative · entry 1

Glanzman Robert · CIK 0001835428 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,281

F1 · shares: This restricted stock award was granted on June 30, 2021 under the Clene Inc. 2020 Stock Plan. The award fully vests on January 15, 2022.

SEC source: 0001562180-21-004605 · primarydocument.xml · nonDerivative · entry 1

Etherington Robert Dee · CIK 0001835330 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 80,076

F1 · shares: This restricted stock award was granted on June 30, 2021 under the Clene Inc. 2020 Stock Plan. The award fully vests on January 15, 2022.

SEC source: 0001562180-21-003703 · primarydocument.xml · nonDerivative · entry 1

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,378,897

F1 · ownership.direct: Mr. Matlin purchased 207,684 shares of common stock of Clene Inc. on May 24, 2021 for a purchase price of $9.63 per share.

SEC source: 0001562180-21-003709 · primarydocument.xml · nonDerivative · entry 1

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by LLC

Disclosed balance after: 51,921

F1 · ownership.direct: Kensington Clene, LLC purchased 51,291 shares of common stock of Clene Inc on May 24, 2021 for a purchase price of $9.63 per share. Ms. Mosca is the sole manager of Kensington Clene, LLC

F2 · ownership.nature: The securities are owned by the Kensington Clene, LLC. Ms. Mosca is the sole manager of and owned a minority interest in Kensington Clene, LLC. The shares owned by the Kensington Clene, LLC may be deemed to be beneficially owned by Ms. Mosca. Ms. Mosca disclaims all shares owned by Kensington Clene, LLC, for which she does not have a pecuniary or profits interest.

SEC source: 0001562180-21-003573 · primarydocument.xml · derivative · entry 2

Gay Jonathon · CIK 0001835422 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-18

F2 · shares: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested

F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested

SEC source: 0001562180-21-003573 · primarydocument.xml · derivative · entry 1

Gay Jonathon · CIK 0001835422 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,894

Underlying: Common Stock · 1,894 shares

Expires 2031-05-18

F1 · shares: This option was granted on May18, 2021 as an option for 1,894 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.

F1 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 1,894 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-003578 · primarydocument.xml · derivative · entry 2

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,358

Underlying: Common Stock · 3,358 shares

Expires 2031-05-18

F2 · shares: This option was granted on May18, 2021 as an option for 3,358 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.

F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 3,358 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-003578 · primarydocument.xml · derivative · entry 1

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-18

F1 · shares: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested

F1 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested

SEC source: 0001562180-21-003577 · primarydocument.xml · derivative · entry 2

Jacobovitz Shalom · CIK 0001835556 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,562

Underlying: Common Stock · 2,562 shares

Expires 2031-05-18

F2 · shares: This option was granted on May18, 2021 as an option for 2,562 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.

F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 2,562 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-003577 · primarydocument.xml · derivative · entry 1

Jacobovitz Shalom · CIK 0001835556 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-18

F1 · shares: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested

F1 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested

SEC source: 0001562180-21-003576 · primarydocument.xml · derivative · entry 2

Stevens John Henry · CIK 0001835543 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,980

Underlying: Common Stock · 1,980 shares

Expires 2031-05-18

F2 · shares: This option was granted on May18, 2021 as an option for 1,980 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.

F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 1,980 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-003576 · primarydocument.xml · derivative · entry 1

Stevens John Henry · CIK 0001835543 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-18

F1 · shares: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested

F1 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested

SEC source: 0001562180-21-003575 · primarydocument.xml · derivative · entry 2

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,626

Underlying: Common Stock · 2,626 shares

Expires 2031-05-18

F2 · shares: This option was granted on May18, 2021 as an option for 2,626 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.

F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 2,626 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-003575 · primarydocument.xml · derivative · entry 1

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-18

F1 · shares: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested

F1 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested

SEC source: 0001562180-21-003574 · primarydocument.xml · derivative · entry 2

Ugwumba Chidozie · CIK 0001835544 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,045

Underlying: Common Stock · 2,045 shares

Expires 2031-05-18

F2 · shares: This option was granted on May18, 2021 as an option for 2,045 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.

F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 2,045 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-003574 · primarydocument.xml · derivative · entry 1

Ugwumba Chidozie · CIK 0001835544 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-18

F1 · shares: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested

F1 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested

SEC source: 0001562180-21-003619 · primarydocument.xml · derivative · entry 2

Costello Fiona · CIK 0001842899 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,894

Underlying: Common Stock · 1,894 shares

Expires 2031-05-18

F2 · shares: This option was granted on May18, 2021 as an option for 1,894 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.

F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 1,894 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-003619 · primarydocument.xml · derivative · entry 1

Costello Fiona · CIK 0001842899 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-18

F1 · shares: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested

F1 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $8.59 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested

SEC source: 0001562180-21-003724 · primarydocument.xml · derivative · entry 2

Gay Jonathon · CIK 0001835422 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-18

F3 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021 to reflect a correction in the exercise price related to the grant of an option for 30,000 shares of common stock of Clene Inc.

F4 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested.

SEC source: 0001562180-21-003724 · primarydocument.xml · derivative · entry 1

Gay Jonathon · CIK 0001835422 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,788

Underlying: Common Stock · 1,788 shares

Expires 2031-05-18

F1 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021. The corrected exercise price is $9.10 and the corrected number of options granted is 1,788.

F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 1,788 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-003725 · primarydocument.xml · derivative · entry 2

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-18

F3 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021 to reflect a correction in the exercise price related to the grant of an option for 30,000 shares of common stock of Clene Inc.

F4 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested.

SEC source: 0001562180-21-003725 · primarydocument.xml · derivative · entry 1

MATLIN DAVID J · CIK 0001251956 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,170

Underlying: Common Stock · 3,170 shares

Expires 2031-05-18

F1 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021. The corrected exercise price is $9.10 and the corrected number of options granted is 3,170.

F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 3,170 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-003726 · primarydocument.xml · derivative · entry 2

Jacobovitz Shalom · CIK 0001835556 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-18

F3 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021 to reflect a correction in the exercise price related to the grant of an option for 30,000 shares of common stock of Clene Inc.

F4 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested.

SEC source: 0001562180-21-003726 · primarydocument.xml · derivative · entry 1

Jacobovitz Shalom · CIK 0001835556 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,418

Underlying: Common Stock · 2,418 shares

Expires 2031-05-18

F1 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021. The corrected exercise price is $9.10 and the corrected number of options granted is 2,418.

F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 2,418 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-003723 · primarydocument.xml · derivative · entry 2

Stevens John Henry · CIK 0001835543 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-18

F3 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021 to reflect a correction in the exercise price related to the grant of an option for 30,000 shares of common stock of Clene Inc.

F4 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested.

SEC source: 0001562180-21-003723 · primarydocument.xml · derivative · entry 1

Stevens John Henry · CIK 0001835543 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,869

Underlying: Common Stock · 1,869 shares

Expires 2031-05-18

F1 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021. The corrected exercise price is $9.10 and the corrected number of options granted is 1,869.

F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 1,869 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-003722 · primarydocument.xml · derivative · entry 2

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-18

F3 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021 to reflect a correction in the exercise price related to the grant of an option for 30,000 shares of common stock of Clene Inc.

F4 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested.

SEC source: 0001562180-21-003722 · primarydocument.xml · derivative · entry 1

Mosca Alison · CIK 0001835537 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,479

Underlying: Common Stock · 2,479 shares

Expires 2031-05-18

F1 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021. The corrected exercise price is $9.10 and the corrected number of options granted is 2,479.

F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 2,479 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-003721 · primarydocument.xml · derivative · entry 2

Ugwumba Chidozie · CIK 0001835544 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-18

F3 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021 to reflect a correction in the exercise price related to the grant of an option for 30,000 shares of common stock of Clene Inc.

F4 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested.

SEC source: 0001562180-21-003721 · primarydocument.xml · derivative · entry 1

Ugwumba Chidozie · CIK 0001835544 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,930

Underlying: Common Stock · 1,930 shares

Expires 2031-05-18

F1 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021. The corrected exercise price is $9.10 and the corrected number of options granted is 1,930.

F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 1,930 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-003756 · primarydocument.xml · derivative · entry 2

Costello Fiona · CIK 0001842899 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 30,000 shares

Expires 2031-05-18

F3 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021 to reflect a correction in the exercise price related to the grant of an option for 30,000 shares of common stock of Clene Inc.

F4 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 30,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest in 12 equal installments of Common Stock on the 18th day of each calendar month, beginning June 18, 2021, until such shares are fully vested.

SEC source: 0001562180-21-003756 · primarydocument.xml · derivative · entry 1

Costello Fiona · CIK 0001842899 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,788

Underlying: Common Stock · 1,788 shares

Expires 2031-05-18

F1 · derivative.exercise_price: This Form 4 amendment is being filed to correct a Form 4 filed on May 18, 2021. The corrected exercise price is $9.10 and the corrected number of options granted is 1,788.

F2 · derivative.exercise_date: This option was granted on May18, 2021 as an option for 1,788 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.10 per share. The options vest immediately upon grant.

SEC source: 0001562180-21-003045 · primarydocument.xml · derivative · entry 1

Gay Jonathon · CIK 0001835422 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 45,000

Underlying: Common Stock · 45,000 shares

Expires 2031-03-31

F1 · shares: This option was granted on April 30, 2021 as an option for 45,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.00 per share. The options vest in 36 equal installments of Common Stock on the last day of each calendar month, beginning May 31, 2021, until such shares are fully vested.

F1 · derivative.exercise_date: This option was granted on April 30, 2021 as an option for 45,000 shares of Common Stock under the Clene Inc. 2020 Stock Plan at an exercise price of $9.00 per share. The options vest in 36 equal installments of Common Stock on the last day of each calendar month, beginning May 31, 2021, until such shares are fully vested.

SEC source: 0001562180-21-003066 · primarydocument.xml · derivative · entry 1

Mortenson Mark · CIK 0001835427 · Chief Science Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 200,000

Underlying: Common Stock · 200,000 shares

Expires 2031-04-30

F1 · shares: This option was granted on April 30, 2021 under the Clene Inc. 2020 Stock Plan. The options vest with respect to the first 25% on May 31, 2022 and then in 36 equal installments of 1/48th of the balance on the last day of each calendar month, beginning June 30, 2022, until fully vested

F1 · derivative.exercise_date: This option was granted on April 30, 2021 under the Clene Inc. 2020 Stock Plan. The options vest with respect to the first 25% on May 31, 2022 and then in 36 equal installments of 1/48th of the balance on the last day of each calendar month, beginning June 30, 2022, until fully vested

SEC source: 0001562180-21-003058 · primarydocument.xml · derivative · entry 1

Glanzman Robert · CIK 0001835428 · Chief Medical Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 95,000

Underlying: Common Stock · 95,000 shares

Expires 2031-04-30

F1 · shares: This option was granted on April 30, 2021 under the Clene Inc. 2020 Stock Plan. The options vest with respect to the first 25% on May 31, 2022 and then in 36 equal installments of 1/48th of the balance on the last day of each calendar month, beginning June 30, 2022, until fully vested

F1 · derivative.exercise_date: This option was granted on April 30, 2021 under the Clene Inc. 2020 Stock Plan. The options vest with respect to the first 25% on May 31, 2022 and then in 36 equal installments of 1/48th of the balance on the last day of each calendar month, beginning June 30, 2022, until fully vested